Try our Advanced Search for more refined results
Health
-
April 20, 2026
Justices Won't Block Multimillion-Dollar Health Fraud Retrial
A man accused of pocketing $12 million as a part of a larger $140 million scheme to defraud public and private healthcare programs can't get out of a second trial, as the U.S. Supreme Court declined to review his case on Monday.
-
April 20, 2026
Catching Up With Delaware's Chancery Court
The Delaware Chancery Court this past week delivered another mix of procedural rulings, fiduciary duty disputes and deal litigation, highlighting both the court's gatekeeping role and its continued focus on stockholder rights and transactional fairness.
-
April 20, 2026
Kirkland, Goodwin Guide Lilly's Potential $7B Kelonia Buy
Kirkland & Ellis LLP-advised pharmaceutical giant Eli Lilly & Co. on Monday announced plans to acquire clinical-stage biotechnology company Kelonia Therapeutics, led by Goodwin Procter LLP, in a deal worth up to $7 billion.
-
April 20, 2026
3 Firms Advise Blue Owl's $2.4B Tampa Healthcare REIT Buy
Blue Owl Capital agreed to pay $2.4 billion for healthcare-focused real estate investment trust Sila Realty Trust in a take-private deal announced Monday advised by Hogan Lovells, Kirkland & Ellis LLP and Dechert LLP.
-
April 20, 2026
High Court Won't Hear 3rd Circ. J&J Class Cert. Appeal
The U.S. Supreme Court on Monday said it won't review a class certification challenge in a securities class action over Johnson & Johnson's cancer-related talc products in the latest development in a closely watched dispute over how courts evaluate class certification in shareholder suits.
-
April 20, 2026
Justices Won't Consider IP Theft Allegations Against Akin
The U.S. Supreme Court on Monday rejected a former Cornell University graduate student's petition trying to revive his malpractice suit against Akin Gump Strauss Hauer & Feld LLP stemming from patent litigation against Illumina Inc. over DNA sequencing intellectual property.
-
April 17, 2026
ITC Clears Apple's Redesigned Apple Watch For Import
The U.S. International Trade Commission on Friday signed off on an administrative law judge's finding that Apple has sufficiently redesigned its smartwatch so it doesn't infringe Masimo Corp.'s patents and is therefore not bound by a 2023 import ban.
-
April 17, 2026
9th Circ. Revives Doctor's PeaceHealth Whistleblower Suit
A Ninth Circuit panel has reinstated a psychiatrist's claims that PeaceHealth Inc. retaliated against him for expressing concerns about potential Medicaid fraud at a Washington hospital, concluding on Friday that the district court overlooked evidence that the employer punished him by not renewing his employment contract.
-
April 17, 2026
Missed Deadline Fatal To Patient's Stapler Suit, 4th Circ. Says
The Fourth Circuit ruled Friday that a surgery patient's missed expert disclosure deadline rightfully ended his case seeking to hold Johnson & Johnson subsidiary Ethicon Endo-Surgery LLC liable for allegedly faulty staples used in his procedure.
-
April 17, 2026
Federal Judge Blocks DOJ's DEI, Citizenship Grant Conditions
A Rhode Island federal judge has temporarily blocked the U.S. Department of Justice from imposing new conditions related to diversity, equity and inclusion activities and immigration status on domestic violence assistance grants, finding a nonprofit coalition likely to succeed in a legal challenge.
-
April 17, 2026
Plea Change Hearing Set For Former Conn. Budget Official
A change of plea hearing has been scheduled for Monday afternoon for Konstantinos M. Diamantis, a former Connecticut budget official, elected politician and attorney facing an impending federal corruption trial for allegedly pocketing bribes while helping end a state Medicaid audit of an optometry practice operated by his friend's fiancée.
-
April 17, 2026
Connecticut Cardiologist Files $4M Suit Over Alleged Ouster
A Connecticut cardiologist alleges he suffered at least $4 million in damages due to his former practice's "repeated disrespect, bad faith" and reputational damage in the medical community for more than a decade, which culminated in his constructive discharge, filing a contract and defamation lawsuit in state court.
-
April 17, 2026
Judge Says USCIS Can't Keep Delaying Iranians' Work Permits
A California federal judge ordered U.S. Citizenship and Immigration Services to unfreeze its processing of work permit applications for several dozen Iranians and a Sudanese national, finding the agency likely violated federal administrative law by indefinitely delaying decisions.
-
April 17, 2026
Up Next At High Court: SEC And FCC Enforcement Authority
The U.S. Supreme Court's final argument session of this term kicks off Monday, when the justices will consider the U.S. Securities and Exchange Commission's authority to seek disgorgement orders against alleged wrongdoers without proving investors were harmed. Here, Law360 breaks down the week's oral arguments.
-
April 17, 2026
3 Key Questions On Trump's Pharma Tariffs
President Donald Trump recently announced 100% tariffs on certain imported pharmaceutical products, with opportunities for drug companies to lower their tariff rates to zero, but questions remain about the requirements for preferential treatment and abilities to administer the regime. Here, Law360 examines three open questions surrounding pharmaceutical tariffs' implementation.
-
April 17, 2026
Verdict For Doctors Affirmed In Fatal E. Coli Infection Appeal
An Illinois appellate panel on Friday affirmed a jury verdict clearing three physicians of liability in a wrongful death suit over a woman's death from septic shock stemming from an undiagnosed E. coli infection, rejecting arguments that evidentiary errors, expert testimony admissions and jury instruction issues warranted a new trial.
-
April 17, 2026
Allstate Says Fla. Surgery Centers Padded Bills For Care
Seven ambulatory surgery centers, a pain clinic and an anesthesia practice that are all run by Surgery Partners conducted "extraordinarily aggressive treatment" on patients involved in minor car crashes to inflate the bills submitted to Allstate, the insurer told a Florida federal court Friday, alleging it paid millions for unnecessary treatment.
-
April 17, 2026
AI Health Co. Illegally Shared Genetic Data, Patients Say
A healthcare company powered by artificial intelligence violated Illinois' genetic privacy law and other consumer protection laws by compelling a genetic testing business it acquired to disclose patients' genetic information, which it then shared through data agreements with pharmaceutical giants such as Eli Lilly and AbbVie, a lawsuit in Illinois federal court says.
-
April 17, 2026
Judge Says Biotech Co. Can't Wipe Cancer Data, For Now
A Texas state judge signed a temporary restraining order on Friday that stops Bellicum Pharmaceuticals Inc. and the consulting firm helping it oversee its dissolution from deleting cell therapy data that the Houston-based MD Anderson Cancer Center says belongs to it.
-
April 17, 2026
Bill Floated To Nix Medical Residency Antitrust Exemption
U.S. Sen. Mike Lee, R-Utah, has introduced legislation to repeal an antitrust exemption given to the medical residency matching program by Congress two decades ago, over concerns about wages and a bottleneck of medical school graduates.
-
April 17, 2026
Healthcare AI Co. Seeks to Drop 3 From Wage Suit
A data science platform said Friday that a former executive, who claims he was not paid after investing $750,000 into the business, cannot drag three out-of-state people loosely connected to the company into a North Carolina federal court and that key claims should be trimmed.
-
April 17, 2026
Aramark Joins NJ Insulin Pricing Suits Against PBMs
Aramark Services Inc. joined multidistrict litigation accusing CVS and pharmacy benefit managers of colluding to inflate the price of insulin.
-
April 17, 2026
Mich. Judge Strikes Pregnancy Limits On Advance Directives
A Michigan state judge struck down statutory rules barring providers from carrying out an incapacitated patient's advance directive to withdraw from life-sustaining treatment if the patient is pregnant, finding they violate reproductive rights enshrined in the state's constitution.
-
April 17, 2026
Latham Leads Kailera's $625M IPO In Obesity Drug Push
Obesity biotech Kailera Therapeutics made its public debut Friday, raising $625 million in an upsized initial public offering that represents one of the largest biotech IPOs in recent years.
-
April 17, 2026
Doc Says Texas Man Can't Sue Over Mailed Abortion Pills
A Texas man suing his ex-girlfriend's out-of-state doctor for prescribing mail-order abortion pills can't prove that the doctor caused the wrongful death of their unborn child, the doctor told a federal court, saying the case should be dismissed because he's not responsible for the woman's actions.
Expert Analysis
-
Series
Alpine Skiing Makes Me A Better Lawyer
Skiing has shaped habits I rely on daily as an attorney — focus, resilience and the ability to remain steady when circumstances shift rapidly — and influences the way I approach legal strategy, client counseling and teamwork, says Isaku Begert at Marshall Gerstein.
-
Weighing The Practical Implications Of SC Kids' Privacy Law
South Carolina's recently enacted Age-Appropriate Code Design Act includes a unique provision: a private right of action for certain violations, but its practical effect remains uncertain, as courts and litigants grapple with complex questions of standing, causation and the definition of actionable harm, say attorneys at K&L Gates.
-
FDA Guidance May Move Goalposts For Form 483 Responses
New draft guidance from the U.S. Food and Drug Administration provides formal insight on how drug manufacturers are expected to respond to Form 483s, raising some concerns about the agency's timelines and expectations, say attorneys at Cooley.
-
2 Strands Of Patent Law In High Court's 'Skinny Label' Case
Amarin v. Hikma, which is set for oral argument in the U.S. Supreme Court this month, highlights the distinction between two different strands of intellectual property law — analogizing a patent to either a property deed or a home, says Jonas McDavit at Spencer West.
-
Telehealth Suit May Redraw Rules For Physician Classification
A new class action in California federal court, Cioppettini v. Mochi Medical, alleging a telehealth company misclassified providers as independent contractors, suggests that traditional markers of physician independence may not apply to telehealth, say attorneys at Reed Smith.
-
Legal Theories In Social Media Verdicts Hold Clues On Impact
Although the two verdicts in cases in New Mexico and California involving Meta and Google are being lumped together, they rest on fundamentally different legal theories, and that distinction determines how their effects may be felt in other jurisdictions, says Mark Morgan at Day Pitney.
-
Senior Housing Demands A Distinct Dealmaking Playbook
An aging population and evolving state regulations underscore a critical reality that senior housing assets can undergo operational or compliance shifts during dealmaking, highlighting the need for unique contractual safeguards like expanded disclosures, anchored notice obligations, and targeted closing conditions and remedies, say attorneys at Goodwin.
-
Why MDLs Slow Down — And How To Speed Them Up
Multidistrict litigation has become central to mass tort practice, but as MDLs grow in size and complexity, so do delays and costs — so tools like the new federal rule governing MDLs, targeted use of special masters and strategically deployed Lone Pine orders are more essential than ever, say attorneys at Ice Miller.
-
A Check-Up On HHS' Push To Implement AI Infrastructure
The U.S. Department of Health and Human Services has made some headway in its efforts to implement artificial intelligence across its agencies, but will have to overcome a number of near-term tests in order to be successful, says Theodore Thompson at Stinson.
-
What A Court Doc Audit Reveals About Erroneous Filings
My audit of 1,522 court documents from last month found that over 95% contained at least one verifiable error, with fewer than 1% showing clear indicators of artificial intelligence use — highlighting above all else that lawyers may want to focus most on strengthening their review processes, says Elliott Ash at ETH Zurich.
-
Exploring When Fraud Asset Freezes Limit Right To Pick Atty
The defendant’s claim in the Seventh Circuit’s pending U.S. v. Shah case that the government restrained his assets until he couldn’t afford his chosen counsel presents a useful case study in how criminal forfeiture procedure interacts with U.S. Supreme Court rulings on Sixth Amendment rights and appealing complex fraud convictions, says Elisha Kobre at Sheppard.
-
Similar-Looking Designs May Not Always Prove Infringement
The Federal Circuit's recent decision in Range of Motion Products v. Armaid is a reminder that even a strikingly similar design might not be found to infringe upon a patented design once design features driven by functionality are filtered out from consideration, say attorneys at BCLP.
-
Series
Mich. Banking Brief: All The Notable Legal Updates In Q1
Michigan's financial services sector saw several significant developments in 2026's first quarter, including the state Department of Insurance and Financial Services' issuance of a bulletin on the use of artificial intelligence and the Michigan House's introduction of a bill based on the Model Money Transmission Modernization Act, say attorneys at Dykema.
-
The Road Ahead For Drug Development In The US
Against the backdrop of drug manufacturers potentially looking to move development efforts overseas, the U.S. Food and Drug Administration's latest guidance on new approach methodologies signals the FDA is likely to be receptive to industry innovation that makes U.S.-based drug development faster or less expensive, creating opportunities and compliance risks for tech companies, say attorneys at Morgan Lewis.
-
FDA's Crackdown On Drug Ads Conflicts With Precedent
Recent U.S. Food and Drug Administration warning letters to drug manufacturers targeting direct-to-consumer advertising raise significant constitutional concerns, and directly clash with prior FDA stances, say attorneys at Sidley.